Keith has been an Investor at BGF since 2015 leading investments across the North of Scotland. BGF are a £2.5bn fund supporting earlier stage and established private businesses, and smaller listed companies in the UK. Prior to joining BGF, Keith was an Investment...

Jane has over 30 years’ experience in the life science industry across biotech, pharma and agrochemicals. She is currently Chair of Spirea and PharmEnable and an NED at Elasmogen, Macomics and Nanosyrinx. Her past roles include Chief Business Officer at F-star, Vice...

With postgraduate qualifications in both business and science, Caroline has a strong commercial, bio-partnering and biologics drug discovery/development background.  She has successfully led teams at Wyeth Inc and subsequently Pfizer Inc in Global Bio-therapeutic...

Andy was one of the founders of Elasmogen and as CTO manages the company’s extensive patent portfolio and IP strategy.  He also holds a number of Non-Exec positions in Life Science and other businesses in Scotland.  Andy is part-time Professor of Medical Biotechnology...

Dr Savvas Neophytou is partner at Deepbridge Capital LLP where he heads up the firm's Life Sciences business. Savvas also co-founded Acorn Partners, a joint venture between Deepbridge Capital, Alder Hey Hospital and software engineers WeAreNova. He is a founding...

Dr Georg Buchner has over 10 years’ experience in Business and Corporate development. He has worked with various biotech companies in the UK and was Amgen’s Business Development Director covering the UK, Scandinavia and Israel. His deal experiences range from M&A...